MEK Consulting

INC Research launches its IPO

Monday, November 10, 2014

Global CRO INC Research launched its initial public offering today, raising $150 million by selling just over 8.1 million shares at $18.50 per share—the middle of the expected $17-$20 range. The stock climbed 9% in early trading past $20.75 before settling to $20 by late afternoon.

[Read More]

INC Research acquires MEK Consulting

Thursday, March 6, 2014

INC Research, a therapeutically focused global CRO, has acquired MEK Consulting, a clinical monitoring-focused CRO based in Lebanon with operations in Greece, Turkey and the Middle East and North Africa (MENA) region. The move supports INC’s strategic business expansion in high-growth regions to deliver global trials, and positions the company as a drug development partner in MENA, which offers access to more than 200 million new patients. 

[Read More]